~~<i id='2BFB057A25'><strike id='2BFB057A25'><tt id='2BFB057A25'><pre id='2BFB057A25'></pre></tt></strike></i>~~

Home» leisure time» explore

explore

author：focus 2025-08-24 23:08:30 Page View：839

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hey, doctors: Don't be no
Next article： The cancer drug shortage isn’t new — and neither are the solutions

explore

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

Prosecutors say FTX founder Sam Bankman

FILE-FTXfounderSamBankman-FriedleavesManhattanfederalcourtinNewYork,Feb.16,2023.Bankman-Friedisharas

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Doctors find melanoma drugs effective against rare brain cancer

Micrographofpapillarycraniopharyngeoma,inthebrain.Sarahkayb/WikimediaCommonsBygoingdowntothemolecula

WSS

explore

explore

comprehensive

explore

Doctors find melanoma drugs effective against rare brain cancer